Scientists link cervical cancer with genetic variant
This article was originally published in Clinica
UK scientists have discovered that a genetic variant of a gene that produces the tumour-suppressor protein p53, could increase a woman's risk of developing cervical cancer seven-fold.
You may also be interested in...
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.